Literature DB >> 11803134

Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.

Catarina M Fernandes1, M Teresa Vieira, Francisco J B Veiga.   

Abstract

Inclusion complexation between nicardipine hydrochloride (NC), a calcium-channel antagonist, and beta-cyclodextrin (beta-CD) or hydroxypropyl-beta-cyclodextrin (HPbetaCD) was evaluated in aqueous environment and in solid state. The phase solubility profiles with both cyclodextrins (CDs) were classified as A(L)-type, indicating the formation of 1:1 stoichiometric inclusion complexes. Stability constants (Ks) were calculated from the phase solubility diagrams and were found to be pH dependent. More stable NC:CDs complexes were formed in alkaline medium in which the drug is in its non-ionized form. Binary systems of NC with CDs, prepared experimentally by different techniques (kneading, evaporation, freeze-drying and spray-drying), were investigated by differential scanning calorimetry, Fourier transformation-infrared spectroscopy, X-ray diffractometry and scanning electron microscopy. From this analysis, evaporation, freeze-drying and spray-drying were found to produce inclusion complexes. In contrast, crystalline drug was still clearly detectable in the kneaded products. The dissolution profiles of the obtained powders were studied in order to define the most appropriate CD and preparation method to originate inclusion complexes, which will be used in the development of a new controlled release formulation of NC. Both the preparation and nature of carrier played an important role in the dissolution performance of the system. However, independently of the preparation technique, all the combinations with HPbetaCD were more effective in achieving the enhancement of the NC dissolution rate, yielding better performances than the corresponding ones with betaCD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11803134     DOI: 10.1016/s0928-0987(01)00208-1

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  25 in total

1.  Physicochemical characterization, in vitro dissolution behavior, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds. preparation and properties of rofecoxib hydroxypropyl beta-cyclodextrin inclusion complex: a technical note.

Authors:  Sanjula Baboota; Mona Dhaliwal; Kanchan Kohli
Journal:  AAPS PharmSciTech       Date:  2005-09-20       Impact factor: 3.246

2.  Physico-chemical characterization and in vitro dissolution assessment of clonazepam-cyclodextrins inclusion compounds.

Authors:  Rakesh Patel; Nirav Purohit
Journal:  AAPS PharmSciTech       Date:  2009-10-29       Impact factor: 3.246

3.  Cellulose-based matrix microspheres of prednisolone inclusion complex: preparation and characterization.

Authors:  Mohanraj Palanisamy; Jasmina Khanam
Journal:  AAPS PharmSciTech       Date:  2011-02-26       Impact factor: 3.246

Review 4.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

5.  Effect of auxiliary substances on complexation efficiency and intrinsic dissolution rate of gemfibrozil-beta-CD complexes.

Authors:  Fareen Sami; Betty Philip; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2009-12-15       Impact factor: 3.246

6.  Preformulation study of the inclusion complex irbesartan-beta-cyclodextrin.

Authors:  Rajashree Hirlekar; Vilasrao Kadam
Journal:  AAPS PharmSciTech       Date:  2009-03-13       Impact factor: 3.246

7.  Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination.

Authors:  Yassin El-Said Hamza; Mona Hassan Aburahma
Journal:  AAPS PharmSciTech       Date:  2009-11-18       Impact factor: 3.246

8.  Characterization of solid maltose microneedles and their use for transdermal delivery.

Authors:  Chandra Sekhar Kolli; Ajay K Banga
Journal:  Pharm Res       Date:  2007-06-28       Impact factor: 4.200

9.  A novel solid dosage form of rifampicin and isoniazid with improved functionality.

Authors:  Mukesh C Gohel; Krishnakant G Sarvaiya
Journal:  AAPS PharmSciTech       Date:  2007-08-24       Impact factor: 3.246

10.  Preparation and pharmacokinetic study of aprepitant-sulfobutyl ether-β-cyclodextrin complex.

Authors:  Lili Ren; Yu Zhou; Ping Wei; Min Li; Guoguang Chen
Journal:  AAPS PharmSciTech       Date:  2013-10-29       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.